Lechowska, Z.; Piotrowska, G.; Gaczoł, A. A.; Król, W.; Kulka, K.; Jurczak, D.; Koronczok-Matusiak, J.; Kafara, Z.; Kowalczyk, D.; Kafara, A.; Szarek, R.; Michta, K. NATALIZUMAB IN MULTIPLE SCLEROSIS – A REVIEW OF DIFFERENT DOSING REGIMENS, SIDE EFFECTS, COMPARISON WITH OTHER DISEASE-MODIFYING THERAPIES WITH ADDITIONAL ATTENTION TO USE IN PREGNANCY AND THE PEDIATRIC POPULATION. IJITSS 2026, 2 (3(51). https://doi.org/10.31435/ijitss.3(51).2026.5801.